US FDA explains info needed for formal product classification requests

The US Food and Drug Administration has issued revised guidance explaining the type of information that companies should submit when seeking a formal determination of the regulatory identity of their product as a drug, device, biological or combination product1,2. The company's request for designation (RFD) results in the FDA assigning the product's pre-market review responsibility based on the product's "primary mode of action".